Opens in a new tab
Monday, 16 November 2026
EVIDENCE. INTERPRETED.
Pharmacally

Duchenne

Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.

Advertisement · Remove ads
970 × 90

Latest in Duchenne

5 stories · every one Fact-Checked
Sarepta_Boston_232_11zonHealth TidingsSarepta’s Duchenne Drugs AMONDYS 45 and VYONDYS 53 Advance Toward Full FDA ApprovalThe FDA has accepted supplemental NDAs for Sarepta’s AMONDYS 45 and VYONDYS 53, exon‑skipping therapies for Duchenne muscular dystrophy.30 Jun 2026 · 3 min read
Fact-Checked
Gemini_Generated_Image_c4o5yoc4o5yoc4o5Clinical TrialsREGENXBIO Completes RGX-202 Confirmatory Study Enrollment, Advances Duchenne Gene Therapy Toward FDA FilingREGENXBIO has completed dosing in the confirmatory study of RGX-202, an investigational gene therapy for Duchenne muscular dystrophy.24 Jun 2026 · 3 min read
Fact-Checked
jose-manuel-esp-seqQU5oDXZM-unsplashClinical TrialsREGENXBIO Delivers Positive Results for Duchenne Therapy RGX-202REGENXBIO announced positive topline data from the pivotal Phase III AFFINITY DUCHENNE trial of RGX-202 in Duchenne Muscular Dystrophy, demonstrating robust microdystrophin expression, functional improvement, and a manageable…14 May 2026 · 3 min read
Fact-Checked
12465Clinical TrialsEntrada Strengthens Its Duchenne Pipeline With Positive ENTR-601-44 Study ReadoutEntrada Therapeutics announced positive topline results from Cohort 1 of the Phase 1/2 ELEVATE-44-201 study evaluating ENTR-601-44 in Duchenne muscular dystrophy patients amenable to exon 44 skipping.7 May 2026 · 3 min read
Fact-Checked
A wheelchair on a sandy beach overlooking the sea on a bright summer day.Clinical TrialsCapricor Reports Phase 3 HOPE-3 Results for Deramiocel in DuchennePhase 3 HOPE-3 results presented at AAN 2026 show Deramiocel delivers meaningful functional benefit in Duchenne muscular dystrophy, supported by both clinical and real-world assessments, as FDA review…23 Apr 2026 · 2 min read
Fact-Checked
Page 1 of 1